Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹32,356.3
₹68,755 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,478.7
₹30,968 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹870.1
₹7,886 Cr
Pharmaceuticals & Drugs
₹473.0
₹7,444 Cr
Pharmaceuticals & Drugs
₹469.3
₹4,283 Cr
Pharmaceuticals & Drugs
₹340.5
₹3,809 Cr
Pharmaceuticals & Drugs
₹103.7
₹2,663 Cr
Pharmaceuticals & Drugs
₹807.1
₹461 Cr
Pharmaceuticals & Drugs
₹83.6
₹407 Cr
Pharmaceuticals & Drugs
₹66.1
₹187 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,478.7
₹4,806 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹473.0
₹4,123 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹469.3
₹2,422 Cr
Pharmaceuticals & Drugs
₹870.1
₹1,946 Cr
Pharmaceuticals & Drugs
₹340.5
₹668 Cr
Pharmaceuticals & Drugs
₹103.7
₹221 Cr
Pharmaceuticals & Drugs
₹83.6
₹85 Cr
Pharmaceuticals & Drugs
₹32,356.3
₹6,590 Cr
Pharmaceuticals & Drugs
₹807.1
₹327 Cr
Pharmaceuticals & Drugs
₹66.1
₹449 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,478.7
₹930 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹473.0
₹347 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹870.1
₹268 Cr
Pharmaceuticals & Drugs
₹469.3
₹189 Cr
Pharmaceuticals & Drugs
₹103.7
₹145 Cr
Pharmaceuticals & Drugs
₹340.5
₹139 Cr
Pharmaceuticals & Drugs
₹83.6
₹4 Cr
Pharmaceuticals & Drugs
₹32,356.3
₹1,452 Cr
Pharmaceuticals & Drugs
₹807.1
₹6 Cr
Pharmaceuticals & Drugs
₹66.1
₹4 Cr

You may also like the below Video Courses